Phenotypic and genotypic characteristics of clinical isolates of pseudomonas aeruginosa: Rate of occurrence and distribution of different serotypes, antimicrobial susceptibility profiles, and molecular typing

Laboratory Medicine

Volumn 39, Issue 3, 2008, Pages 155-161

  Jamasbi, Roudabeh J ^a   Proudfoot, Eric M ^a  

^a BOWLING GREEN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; DNA FINGERPRINTING; GENETIC VARIABILITY; GENOTYPE; MOLECULAR TYPING; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; SEROTYPE;

PSEUDOMONAS AERUGINOSA;

EID: 62749120275     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/1BAWW0951N7V71CE     Document Type: Article

References (41)

1. Estahbanati HK, Kashani PP, Ghanaatpisheh F. Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics. Burns. 2002;28:340-348.
2. Jones AM, Govan JR, Doherty CJ, et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet. 2001;358:557-558.
3. Kielhofner M, Atmar RL, Hamill RJ, et al. Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis. 1992; 14:403-411.
4. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med. 2000;162:891-895.
5. Koch C, Rainisio M, Madessani U, et al. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: Data from the European Epidemiological Registry of Cystic Fibrosis. Pediatr Pulmonol. 2001;32:343-350.
6. Patzer J, Walkiewicz R, Dzierzanowska D. Susceptibility of Pseudomonas aeruginosa strains isolated from hospitalized children. J Antimicrob Chemother. 1986;18:45-49.
7. Pitt TL. Epidemiological typing of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 1988;7:238-247.
8. Liu PV, Matsumoto H, Kusama H, et al. Survey of heat-stable, major somatic antigen on Pseudomonas aeruginosa. Int J Syst Bacteriol. 1983;33:256-264.
9. Liu PV, Wang S. Three new major somatic antigens of Pseudomonas aeruginosa. J Clin Microbiol. 1990;28:922-925.
10. Pirnay JP, De Vos D, Cochez C, et al. Pseudomonas aeruginosa displays an epidemic population structure. Environ Microbiol. 2002;4:898-911.
11. Hernández J, Ferrus MA, Hernández M, et al. Arbitrary primed PCR fingerprinting and serotyping of clinical Pseudomonas aeruginosa strains. FEMS Immunol Med Microbiol. 1997;17:37-47.
12. Kersulyte D, Struelens MJ, Deplano A, et al. Comparison of arbitrarily primed PCR and macrorestriction (pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients. J Clin Microbiol. 1995;33:2216-2219.
13. Jamasbi RJ. Frequency and distribution of Pseudomonas aeruginosa serotypes O:3, O:6, O:11 in three northwestern Ohio hospitals as determined by ELISA using specific monoclonal antibodies. Ohio J Sci. 1999;99:10-15.
14. Jamasbi RJ, Kennel SJ, Waters LC, et al. Genetic analysis of Pseudomonas aeruginosa by enterobacterial repetitive intergenic consensus polymerase chain reaction (PCR) and arbitrarily primed PCR: Gel analysis compared with microchip gel electrophoresis. Infect Control Hosp Epidemiol. 2004;25:65-71.
15. Gales AC, Jones RN, Turnidge J, et al. Characterization of Pseudomonas aeruginosa isolates: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the Global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32:S146-S155.
16. Crouch-Brewer S, Wunderink RG, Jones CB, et al. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest. 1996; 109:1019-1029.
17. Wiener-Kronish JP, Frank DW, Sawa T. Mechanisms of lung epithelial cell injury by acute Pseudomonas aeruginosa. In: RSB Clark and JA Carcillo, eds. Molecular biology of acute lung injury. Kluwer Academic Publishers; Boston. MA; 2001:149-161.
18. Center for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May1999. A J Infect Cont. 1999;27:520-532.
19. Vincent JL, Bihari DL, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) study. J Am Med Associat. 1995;274:639-644.
20. Holder IA, Volpel K, Ronald G, et al. Studies on multiple Pseudomonas aeruginosa from individual burn patients by RFLP, "O" antigen serotyping and antibiogram analysis. Burns. 1995; 21:441-444.
21. Vidal F, Mensa J, Almela M, et al. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch Intern Med. 1996;156:2121-2126.
22. Müller-Premru M, Gubina M. Serotype, antimicrobial susceptibility and clone distribution of Pseudomonas aeruginosa in a university hospital. Zentralbl Bakteriol. 2000;289:857-865.
23. Tassios PT, Gennimata V, Maniatis AN, et al. Greek Pseudomonas aeruginosa Study Group. Emergence of multidrug resistance in ubiquitous and dominant Pseudomonas aeruginosa serogroup O:11. J Clin Microbiol. 1998;36:897-901.
24. Lomholt JA, Poulsen K, Kilian M. Epidemic population structure of Pseudomonas aeruginosa: Evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect Immun. 2001;69:6284-6295.
25. Feil EJ, Holmes EC, Bessen DE, et al. Recombination within natural populations of pathogenic bacteria. Short-term empirical estimates and longterm phylogenetic consequences. Proc Natl Acad Sci USA. 2001;98:182-187.
26. Knirel YA, Vinogradov EV, Kocharova NA, et al. The structure of O-specific polysaccharides and serological classification of Pseudomonas aeruginosa (review). Acta Microbiol Hung. 1988;35:3-24.
27. Bouza E, Garcia-Garrote F, Cercenado E, et al, for the Spanish Pseudomonas aeruginosa study group. Pseudomonas aeruginosa: A survey of resistance in 136 hospitals in Spain. Antimicrob Agents Chemother. 1999;43:981-982.
28. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare? Clin Infect Dis. 2002;34: 634-640.
29. Nordmann P, Ronco E, Naas T, et al. Characterization of novel extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1993;37:962-969.
30. Bukholm G, Tannaes T, Kjelsberg AB, et al. An outbreak of multidrug resistant Pseudomonas aeruginosa associated with increased risk of patient death in an intensive care unit. Infect Control Hosp Epidemiol. 2002;23:441-446.
31. Pitt TL, Livermore DM, Pitcher D, et al. Multiresistant serotype O:12 Pseudomonas aeruginosa: Evidence for a common strain in Europe. Epidemiol Infect. 1989;103:565-576.
32. Rossello J, Olona M, Campins M, et al. Investigation of an outbreak of nosocomial infection due to a multiple drug-resistant strain of Pseudomonas aeruginosa. J Hosp Infect. 1992;20:87-96.
33. Bert F, Lambert-Zechovsky N. Antibiotic resistance pattern in Pseudomonas aeruginosa: An 8-year surveillance study in a French hospital. Int J Antimicrob Agents. 1997;9:107-112.
34. Hancock RE. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis. 1998;27:S93-S99.
35. Nikaido H. Antibiotic resistance caused by gram-negative multidrug efflux pumps. Clin Infect Dis. 1998;27:S32-S41.
36. Westbrock-Wadman S, Sherman DR, Hickey MJ, et al. Characterization of a Pseudomonas aeruginosa Efflux Pump contributing to aminoglycoside impermeability. Antimicrob Agents Chemother. 1999;43:2975-2983.
37. Pagani L, Mantengoli E, Migliavacca R, et al. Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase in northern Italy. J Clin Microbiol. 2004;42:2523-2529.
38. Vosahlikova S, Drevinek P, Cinek O, et al. High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic. Res Microbiol. 2007;158:324-329.
39. Römling U, Schmidt KD, Tümmler B. Large genome rearrangements discovered by the detailed analysis of 21 Pseudomonas aeruginosa clone C isolates found in environment and disease habitats. J Mol Biol. 1997;271:386-404.
40. Finnan S, Morrissey JP, O'Gara F, et al. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol. 2004;42:5783-5792.
41. Kiewitz C, Tümmler B. Sequence diversity of Pseudomonas aeruginosa: Impact on population structure and genome evolution. J Bacteriol. 2000;182:3125-3135.